跳至主要内容
临床试验/DRKS00013750
DRKS00013750已完成不适用

Prospective, longitudinal, observational study of novel serum/plasma biomarkers of disease activity in patients with inflammatory bowel disease

Medizinische Hochschule Hannover0 个研究点目标入组 60 人开始时间: 2018年3月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Outpatient visit for study-independent medical reasons
  • - Patients with a) Crohn's disease, b) Ulcerative Colitis, c) Microscopic colitis
  • - Patients before therapy start with an (extended) anti-inflammatory treatment (5-ASA, Budesonid, Prednisolon, Azathioprin, Methotrexat, anti-TNF, Vedolizumab, Ustekinumab, Tofacitinib)

排除标准

  • - Diseases which prevent the patient from understanding the nature and the concept of the clinical trial
  • - Indications that the patient will presumably not comply with the protocol (e.g. adherence problem)

研究者

发起方
Medizinische Hochschule Hannover

相似试验

Prospective, longitudinal, observational study of... | 临床试验